Engineers Gate Manager’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.3K Buy
+22,658
New +$40.2K ﹤0.01% 2101
2025
Q2
Sell
-13,212
Closed -$10.7K 2200
2025
Q1
$10.7K Buy
+13,212
New +$15.2K ﹤0.01% 2099
2024
Q4
Sell
-11,978
Closed -$12.5K 2264
2024
Q3
$12.5K Buy
+11,978
New +$16.4K ﹤0.01% 2050
2022
Q4
Sell
-11,915
Closed -$115K 1711
2022
Q3
$115K Sell
11,915
-22,685
-66% -$230K 0.01% 1429
2022
Q2
$251K Sell
34,600
-640
-2% -$5.57K 0.01% 1522
2022
Q1
$455K Buy
+35,240
New +$448K 0.02% 1113
2020
Q2
Sell
-42,357
Closed -$687K 1720
2020
Q1
$687K Sell
42,357
-19,372
-31% -$358K 0.05% 605
2019
Q4
$1.11M Buy
+61,729
New +$1.14M 0.05% 583

Other funds holding CHRS